MedPath

Open-label Placebo in Manual Therapy

Phase 2
Recruiting
Conditions
Low Back Pain, Recurrent
Registration Number
NCT06306742
Lead Sponsor
Studio Osteopatico Busto Arsizio
Brief Summary

to investigate the effects of placebo in patients affected by low-back pain.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
30
Inclusion Criteria

Adult patients (+18 years) who complain of chronic non-specific low back pain for at least 3 months with or without pain exacerbations at the time of recruitment, will be included.

-Patients will need to have a diagnosis of low back pain made by a physician

Exclusion Criteria
  • pathologies such as ankylosing spondylitis, infections, fractures, tumors or metastases.
  • Pregnant women
  • patients with previous spinal surgery or undergoing cortisone therapy in the 6 months prior to the trial
  • diseases that may affect the interpretation of results such as fibromyalgia
  • patients currently being treated by other specialists or other manual therapists

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Change in Numeric Rating ScaleChange from baseline of numeric rating scale at week 2, 4 and 8.

a verbal determination of a pain level on a scale from 0 to 10, in which 0 represents no pain and 10 represents excruciating pain.

Adverse effectsthrough study completion (8 weeks)

Number and types of adverse effects occurred after intervention

Secondary Outcome Measures
NameTimeMethod
Change in measures of Von Frey filamentsfrom baseline at week 2,4 and 8.

Changes in pressure measures

Changes in algometer measurementsfrom baseline at week 2, 4 and 8

Changes in pressure with algometer

Trial Locations

Locations (1)

CTFO

🇮🇹

Saronno, Varese, Italy

CTFO
🇮🇹Saronno, Varese, Italy
CFTO
Contact
+39 02 96701013
cfto@aimoedu.it

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.